TWST Twist Bioscience Corporation Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

TWST [NASD]

Twist Bioscience Corporation

Healthcare | Diagnostics & Research | USA

statements

Index	-	P/E	-	EPS (ttm)	-4.42	Insider Own	3.20%	Shs Outstand	37.16M	Perf Week	10.03%
Market Cap	2.92B	Forward P/E	-	EPS next Y	-1.84	Insider Trans	-19.21%	Shs Float	35.52M	Perf Month	9.66%
Income	-146.50M	PEG	-	EPS next Q	-0.64	Inst Own	81.40%	Short Float	13.81%	Perf Quarter	57.58%
Sales	65.80M	P/S	44.39	EPS this Y	-46.50%	Inst Trans	4.56%	Short Ratio	9.04	Perf Half Y	89.96%
Book/sh	7.11	P/B	8.67	EPS next Y	48.10%	ROA	-61.80%	Target Price	47.00	Perf Year	108.45%
Cash/sh	4.86	P/C	12.69	EPS next 5Y	-	ROE	-80.90%	52W Range	18.52 - 68.10	Perf YTD	193.62%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-68.30%	52W High	-9.46%	Beta	-
Dividend %	-	Quick Ratio	8.30	Sales past 5Y	-	Gross Margin	22.30%	52W Low	232.94%	ATR	4.21
Employees	414	Current Ratio	8.60	Sales Q/Q	41.90%	Oper. Margin	-	RSI (14)	60.51	Volatility	8.66% 7.16%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	8.10%	Profit Margin	-	Rel Volume	1.47	Prev Close	65.70
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Aug 06 AMC	Payout	-	Avg Volume	542.75K	Price	61.66
Recom	2.00	SMA20	7.21%	SMA50	28.74%	SMA200	88.97%	Volume	798,466	Change	-6.15%

May-31-19

Initiated

Evercore ISI

Outperform

Nov-26-18

Initiated

JP Morgan

Neutral

$27

Aug-06-20 07:10PM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM	Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results Business Wire
Aug-04-20 08:00AM	Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies Business Wire +5.61%
Jul-30-20 12:34PM	Will Twist Bioscience (TWST) Report Negative Q3 Earnings? What You Should Know Zacks
08:00AM	Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020 Business Wire
Jul-28-20 08:00AM	Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19 Business Wire
Jul-23-20 08:00AM	Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy Business Wire
Jul-22-20 08:21AM	Twist Bioscience Has Gained 186% in 2020. Is the Synbio Stock a Buy? Motley Fool
08:00AM	Twist Bioscience Launches Synthetic Controls for Respiratory Viruses Business Wire
Jul-16-20 08:00AM	Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody Therapeutics for Dogs and Cats Business Wire -5.43%
Jul-15-20 02:20PM	Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treating COVID-19 Business Wire
Jul-08-20 08:00AM	Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities Business Wire +11.82%
Jul-01-20 08:12AM	The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes Benzinga
Jun-30-20 08:00AM	Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line Business Wire +7.83%
Jun-28-20 05:23PM	Hedge Funds Keep Buying Twist Bioscience Corporation (TWST) Insider Monkey
Jun-11-20 08:00AM	Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls Business Wire -7.57%
Jun-09-20 08:30AM	Twist Bioscience Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates PR Newswire
Jun-08-20 04:05PM	Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Jun-03-20 10:16PM	Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock Business Wire
04:27PM	Twist Bioscience Announces Proposed Public Offering of Common Stock Business Wire
Jun-01-20 08:00AM	Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection Business Wire +5.40%
May-26-20 08:00AM	Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference Business Wire -5.15%
May-17-20 04:15PM	Schrodinger Shares Have More Than Tripled Since IPO GuruFocus.com
May-12-20 08:00AM	Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference Business Wire
May-08-20 05:30PM	Twist Bioscience Corp (TWST) Q2 2020 Earnings Call Transcript Motley Fool +6.71%
May-07-20 08:10PM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	Twist Bioscience Reports Second Quarter Fiscal 2020 Financial Results Business Wire
May-06-20 08:00AM	Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2 Business Wire +10.31%
Apr-30-20 08:00AM	Twist Bioscience to Report Fiscal 2020 Second Quarter Financial Results on Thursday, May 7, 2020 Business Wire
Apr-28-20 12:33PM	Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Apr-20-20 08:30AM	Twist Bioscience's Shares March Higher, Can It Continue? Zacks
08:00AM	Twist Bioscience Expands Flexibility of Clonal Genes for Pharmaceutical, Biotechnology and Industrial Chemical Research Business Wire
Apr-13-20 10:55AM	Why Twist Bioscience (TWST) Stock Might be a Great Pick Zacks
Mar-26-20 08:00AM	Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19 Business Wire +9.01%
Mar-25-20 08:00AM	Twist Bioscience Synthetic SARS-CoV-2 RNA Controls Added to FDA Website as Reference Materials Business Wire
Mar-24-20 04:23PM	Biotech stocks have held up better than the broader market and these five are potential winners MarketWatch +10.68%
Mar-16-20 08:00AM	Twist Announces Availability of Next-Generation Sequencing Target Enrichment Panel for SARS-CoV-2/COVID-19 Research Business Wire -22.85%
Mar-12-20 08:00AM	Twist Bioscience Announces Availability of Synthetic SARS-CoV-2 RNA Controls Business Wire -14.68%
Feb-26-20 08:05AM	Twist Bioscience and SOPHiA GENETICS Collaborate to Offer Optimized Genomic Solutions Business Wire
08:00AM	Twist Bioscience to Present at the Cowen 40th Annual Health Care Conference Business Wire
Feb-25-20 08:00AM	Twist Bioscience and Miroculus Agree to Collaborate on Next-Generation Sequencing Target Enrichment and Library Preparation Tools for Clinical Research Business Wire
Feb-24-20 04:05PM	Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
08:00AM	Twist Bioscience Launches New NGS Solutions, Highlights Customers at 2020 Advances in Genome Biology and Technology Conference Business Wire
06:00AM	GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to Worlds Most Accessible Highly Accurate Sequencer Business Wire
Feb-19-20 07:51PM	Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock Business Wire -6.94%
Feb-18-20 04:11PM	Twist Bioscience Announces Proposed Public Offering of Common Stock Business Wire
Feb-12-20 08:00AM	Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System Business Wire
Feb-06-20 02:30PM	Twist Bioscience Corp. to Host Earnings Call ACCESSWIRE +16.30%
07:47AM	The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs Benzinga
Jan-31-20 04:18PM	CORRECTING and REPLACING Twist Bioscience Announces Completion of $50 Million Offering Priced At-The-Market Business Wire
Jan-23-20 11:26AM	Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus PR Newswire
09:15AM	Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus PR Newswire
08:00AM	Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020 Business Wire
Jan-15-20 12:00PM	Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program Business Wire +9.40%
08:00AM	Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery Business Wire
Jan-13-20 08:00AM	Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer Setting Stage for Future Growth Business Wire
Jan-06-20 08:00AM	Twist Bioscience to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire +6.94%
Dec-17-19 07:21PM	Hedge Funds Have Never Been This Bullish On Twist Bioscience Corporation (TWST) Insider Monkey
Dec-12-19 07:38AM	The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga
Dec-11-19 04:05PM	Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results Business Wire
08:00AM	Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Business Wire
Nov-22-19 08:24AM	If You Had Bought Twist Bioscience (NASDAQ:TWST) Stock A Year Ago, You'd Be Sitting On A 13% Loss, Today Simply Wall St.
Nov-20-19 08:01AM	Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019 Business Wire +5.35%
08:00AM	Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer Business Wire
Nov-13-19 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences Business Wire
Nov-08-19 08:00AM	Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Business Wire
Oct-30-19 08:00AM	Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific Business Wire
Oct-28-19 02:15PM	Hedge Funds Have Never Been This Bullish On Twist Bioscience Corporation (TWST) Insider Monkey
Oct-25-19 08:00AM	Twist Bioscience Appoints Seasoned Life Sciences Industry Executive Nicolas M. Barthelemy to Board of Directors Business Wire
Oct-24-19 02:01PM	Praesens Foundation, Institut Pasteur, Institut Pasteur de Dakar, University of Nebraska Medical Center, Twist Bioscience Consortium Win Prix Galien MedStartUp Award Business Wire
Oct-16-19 08:00AM	Twist Bioscience Showcases Next-Generation Sequencing Products and Results at American Society for Human Genetics 2019 Annual Meeting Business Wire
Oct-01-19 08:00AM	Twist Bioscience Showcases New Innovation Lab at SynBioBeta 2019 Business Wire -5.40%
Sep-24-19 08:00AM	Twist Bioscience to Present at SynBioBeta 2019 Business Wire
Aug-30-19 08:00AM	Twist Bioscience to Present at Two Investor Conferences in September Business Wire
Aug-28-19 08:15PM	Twist Bioscience Corp (TWST) COO William Banyai Sold $614,240 of Shares GuruFocus.com +5.44%
Aug-19-19 07:14PM	Twist Bioscience Grows Q3 Revenue 108%, but Losses Pile Up Motley Fool
Aug-02-19 07:43PM	Twist Bioscience Corporation (TWST) Q2 2019 Earnings Call Transcript Motley Fool -7.68%
Aug-01-19 04:05PM	Twist Bioscience Reports Third Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
Jul-29-19 08:00AM	Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research Business Wire
Jul-25-19 08:01AM	Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA Business Wire
08:00AM	Twist Bioscience to Report Fiscal 2019 Third Quarter Financial Results on Thursday, August 1, 2019 Business Wire
Jun-17-19 08:00AM	Twist Bioscience Launches Mouse Exome to Power Genetic Research Business Wire
May-28-19 08:00AM	Twist Bioscience to Present at the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 08:00AM	Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan Business Wire
08:00AM	Collaboration of Four Biotech Companies Showcases High Throughput DNA Assembly Platform for Diverse Applications Business Wire
May-16-19 08:00AM	Twist Bioscience to Present at the UBS Global Healthcare Conference Business Wire
May-14-19 08:41AM	Twist Bioscience (TWST) Catches Eye: Stock Jumps 8% Zacks
May-13-19 11:55AM	Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire +7.97%
May-08-19 08:03PM	Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock Business Wire
May-06-19 04:10PM	Twist Bioscience Announces Proposed Public Offering of Common Stock Business Wire
May-02-19 07:00AM	Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019 Motley Fool
Apr-30-19 07:45PM	Twist Bioscience Corporation (TWST) Q2 2019 Earnings Call Transcript Motley Fool -14.71%
06:22PM	Twist Bioscience: Fiscal 2Q Earnings Snapshot Associated Press
04:05PM	Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
Apr-25-19 08:00AM	Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers Business Wire
Apr-18-19 08:00AM	Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019 Business Wire
Apr-15-19 08:00AM	Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry Business Wire
Apr-11-19 08:00AM	Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics Business Wire
Apr-10-19 08:43AM	Twist Bioscience (TWST) Looks Good: Stock Adds 6.5% in Session Zacks
Apr-09-19 08:01AM	Twist Bioscience Customized Libraries for Biologics Discovery Highlighted at PEGS Boston 2019 Business Wire +6.49%

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has collaboration agreements with Pandion Therapeutics, Inc. and Schrodinger Inc. It also has a partnership with Serimmune Inc. to identify and evaluate SARS-CoV-2 therapeutic antibody candidates. The company was founded in 2013 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Finn Patrick John	Chief Commercial Officer	Jul 31	Option Exercise	8.82	2,358	20,798	39,097	Aug 04 04:46 PM
Finn Patrick John	Chief Commercial Officer	Jul 31	Option Exercise	8.82	2,358	20,798	39,097	Aug 04 04:42 PM
Finn Patrick John	Chief Commercial Officer	Jul 23	Sale	59.11	2,358	139,375	36,739	Jul 27 05:31 PM
Leproust Emily M.	President & CEO	Jul 21	Sale	59.33	15,000	889,967	703,055	Jul 22 05:48 PM
Banyai William	See Remarks	Jul 16	Sale	53.12	11,000	584,282	493,592	Jul 17 06:10 PM
Banyai William	See Remarks	Jul 15	Sale	55.61	11,000	611,694	504,592	Jul 17 06:10 PM
Finn Patrick John	Chief Commercial Officer	Jul 08	Option Exercise	26.66	28,820	768,341	39,097	Jul 10 06:45 AM
Banyai William	See Remarks	Jul 08	Sale	53.15	25,000	1,328,793	515,592	Jul 10 04:15 PM
Leproust Emily M.	President & CEO	Jul 08	Sale	50.37	19,700	992,289	718,055	Jul 10 06:44 AM
Leproust Emily M.	President & CEO	Jul 07	Sale	49.00	300	14,700	737,755	Jul 10 06:44 AM
Finn Patrick John	Chief Commercial Officer	Jul 07	Sale	47.11	16,084	757,658	10,277	Jul 10 06:45 AM
Finn Patrick John	Chief Commercial Officer	Jul 06	Sale	46.69	11,336	529,271	26,361	Jul 08 05:52 PM
Finn Patrick John	Chief Commercial Officer	Jul 02	Sale	46.68	1,400	65,354	37,697	Jul 07 08:05 PM
Finn Patrick John	Chief Commercial Officer	Jun 25	Option Exercise	8.82	841	7,418	39,097	Jun 29 06:05 PM
Daniels Mark	See Remarks	Jun 16	Option Exercise	5.95	3,536	21,039	57,254	Jun 17 05:18 PM
Banyai William	See Remarks	Jun 16	Sale	38.75	11,000	426,204	540,592	Jun 17 05:18 PM
Daniels Mark	See Remarks	Jun 16	Sale	38.80	3,536	137,181	53,718	Jun 17 05:18 PM
Green Paula	VP of Human Resources	Jun 15	Option Exercise	5.95	16,833	100,156	39,448	Jun 17 05:17 PM
Banyai William	See Remarks	Jun 15	Sale	38.15	11,000	419,607	551,592	Jun 17 05:18 PM
Green Paula	VP of Human Resources	Jun 15	Sale	38.00	16,833	639,654	22,615	Jun 17 05:17 PM
Daniels Mark	See Remarks	Jun 10	Sale	40.00	1,962	78,480	53,718	Jun 11 06:42 PM
Weiss Patrick	Chief Operating Officer	Jun 08	Sale	37.25	20,000	744,940	57,606	Jun 10 04:44 PM
Leproust Emily M.	President & CEO	Jun 01	Sale	39.14	24,500	958,888	738,055	Jun 03 05:03 PM
Banyai William	See Remarks	Jun 01	Sale	40.01	20,113	804,641	562,592	Jun 03 05:04 PM
Finn Patrick John	Chief Commercial Officer	May 29	Option Exercise	8.82	841	7,418	38,256	Jun 01 06:27 PM
Finn Patrick John	Chief Commercial Officer	May 28	Sale	37.09	2,116	78,485	37,415	Jun 01 06:27 PM
Finn Patrick John	Chief Commercial Officer	May 26	Option Exercise	38.46	4,207	161,801	39,531	May 28 07:44 PM
Leproust Emily M.	President & CEO	May 26	Sale	39.07	10,593	413,827	762,555	May 27 06:26 PM
Leproust Emily M.	President & CEO	May 22	Sale	39.27	14,513	569,923	773,148	May 27 06:26 PM
Leproust Emily M.	President & CEO	May 21	Sale	39.54	14,438	570,852	787,661	May 22 09:07 PM
Banyai William	See Remarks	May 21	Sale	40.03	4,887	195,629	582,705	May 22 09:07 PM
Leproust Emily M.	President & CEO	May 20	Sale	39.75	40,956	1,627,811	805,106	May 22 09:07 PM
Banyai William	See Remarks	May 20	Sale	39.66	22,000	872,617	588,267	May 22 09:07 PM
Finn Patrick John	Chief Commercial Officer	May 20	Sale	39.69	4,207	166,957	35,999	May 22 09:06 PM
Weiss Patrick	Chief Operating Officer	Feb 19	Sale	28.66	1,742	49,924	74,037	Feb 20 04:28 PM
Weiss Patrick	Chief Operating Officer	Feb 18	Sale	30.69	4,090	125,538	75,779	Feb 20 04:28 PM
Banyai William	See Remarks	Feb 18	Sale	30.71	11,000	337,777	611,033	Feb 20 04:27 PM
Weiss Patrick	Chief Operating Officer	Feb 06	Option Exercise	26.66	7,680	204,749	85,950	Feb 10 08:10 PM
Weiss Patrick	Chief Operating Officer	Feb 06	Sale	28.16	7,680	216,253	79,869	Feb 10 08:10 PM
Weiss Patrick	Chief Operating Officer	Feb 05	Sale	26.18	4,089	107,035	79,869	Feb 06 09:01 PM
Weiss Patrick	Chief Operating Officer	Feb 04	Sale	26.21	4,090	107,193	83,958	Feb 06 09:01 PM
Finn Patrick John	Chief Commercial Officer	Jan 23	Option Exercise	8.82	15,000	132,300	40,472	Jan 24 04:34 PM
Weiss Patrick	Chief Operating Officer	Jan 22	Sale	22.46	4,089	91,842	88,048	Jan 23 04:59 PM
Finn Patrick John	Chief Commercial Officer	Jan 22	Sale	22.52	15,000	337,831	25,472	Jan 24 04:34 PM
Weiss Patrick	Chief Operating Officer	Jan 21	Sale	22.29	4,089	91,141	92,137	Jan 23 04:59 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience